Particle.news

Anvisa Bans Moringa Products From Moringa da Paz

The regulator ordered seizures under a nationwide prohibition after safety reviews left unresolved risks of genetic damage plus liver injury.

Overview

  • Anvisa’s measure forbids the manufacture, distribution, sale, publicity and use of four Moringa da Paz items and requires seizure of all covered lots.
  • The ban covers specific products listed in Resolução 3.628/2026 and the rule was published in the Diário Oficial da União, giving it national legal effect.
  • Anvisa says Moringa oleifera lacks proven safety as a food ingredient in any form of presentation, including teas, powders, capsules, bars and beverages.
  • The agency based the decision on repeated safety assessments that could not rule out genotoxicity, meaning potential DNA damage, and hepatotoxicity, meaning possible liver harm.
  • The move expands enforcement beyond a narrow recall by treating all moringa presentations as unverified for food use, which could affect makers, retailers and consumers of supplements and foods containing moringa.